Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Beta Bionics, Inc.NASDAQ: BBNX
Other Current Assets · Q1 FY2026 · quarter ended Mar 2026
Other current assets rises 35.0% from a year ago
Other current assets stood at $351K at the end of Q1 FY2026, up 35.0% from a year earlier and up 251.0% from the prior quarter. Over 3 fiscal years it compounded at -26.3% a year.
Context
- Other current assets amounted to 0.1% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other current assets keeps rising in the next quarterly balance sheet after a +35.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 100K USD
- Year-over-year change
- -90.5%
- 3-year CAGR
- -26.3%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 100K | -90.5% |
| FY2024 | 2024-12-31 | 1.05M | +281.8% |
| FY2023 | 2023-12-31 | 275K | +10.0% |
| FY2022 | 2022-12-31 | 250K | — |
Other Current Assets vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +35.0% is the 4th highest of 7, against a peer median of +49.1%.
- Other current assets amounts to 0.1% of total assets for BBNX, versus a peer median of 1.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 3.85B DKK | -68.6% | +27.8% | 0.6% | |
| Jun 2026 | $130M USD | +96.7% | +10.0% | 2.0% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $72M USD | — | — | 1.5% |
| Mar 2026 | $49.77M USD | +83.8% | +62.8% | 4.3% | |
| Mar 2026 | $39.4M USD | +14.5% | +22.3% | 5.3% | |
| Mar 2026 | $2.31M USD | +177.6% | +25.4% | 0.9% | |
| Mar 2026 | $351K USD | +35.0% | -26.3% | 0.1% | |
| Jun 2026 | $0 USD | -100.0% | +41.5% | 0.0% | |
| Peer median (excluding BBNX) | — | +49.1% | +26.6% | 1.5% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.